1. Home
  2. Animal Drug Index - T
  3. Thyrokare

Animal NDC 59051-9128-9 Thyrokare

Levothyroxine Sodium

Animal Product Information

Field Name Field Value
Animal NDC Code 59051-9128-9
Proprietary Name Thyrokare What is the Proprietary Name?
The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
Non-Proprietary Name Levothyroxine Sodium What is the Non-Proprietary Name?
The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
Labeler Name Neogen Corporation-mercer Rd
Product Type Prescription Animal Drug
Usage Information
    For use in horses for correction of conditions associated with low circulating thyroid hormone (hypothyroidism).
Active Ingredient(s)
  • Levothyroxine Sodium
Marketing Category UNAPPROVED DRUG OTHER What is the Marketing Category?
Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Thyrokare Images

Thyrokare Animal Product Labeling Information

The product labeling information includes all published material associated to a drug. Product labeling documents include information like generic names, active ingredients, ingredient strength dosage, routes of administration, appearance, usage, warnings, inactive ingredients, etc.

Table of Contents



Indications:



For use in horses for correction of conditions associated with low circulating thyroid hormone (hypothyroidism).


Dosage:



The suggested initial dose is 0.5 to 3.0 mg levothyroxine sodium (T-4) per 100 lbs of body weight (1 to 6 mg per 100 kg) once per day or in divided doses. Response to the administration of ThyroKare Powder should be evaluated clinically until an adequate maintenance dose is established. In most horses, the total daily dose of T-4 is in the range of 6 to 36 mg. Serum T-3 and T-4 values can vary greatly among inidividual horses on thyroid supplementation. Dosages should be individualized and animals should be monitored daily for clinical signs of hyperthyroidism or hypersensitivity.

Administration:

ThyroKare Powder can be administered by mixing the daily dose in the concentrate or by top dressing on the grain, preferably rolled or ground. To facilitate the proper adhesion of ThyroKare Powder to the ration, slightly moisten the grain with water or a liquid supplement.


Precaution:



Store at 20°-25°C (68°-77°F) with excursions between 15°-30°C (59°-86°F) and protect from light.


Warning:



Administer with caution to animals with clinically significant heart disease, hypertension, or other complications for which a sharply increased metabolic rate might prove hazardous. Use in pregnant mares has not been evaluated.


Principal Display Panel 10 Pound Pail



NDC: 59051-9128-9

ThyroKare™ Equine Powder

Levothyroxine Sodium USP

(0.22%)

CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian.

NEOGENVet

Net Contents: 10 lb (4.536 kg)

L3396-0816


* The information on this page is for an ANIMAL PRODUCT, please review the complete disclaimer below.